Ocular gene therapy holds promise for the treatment of numerous blinding disorders.
Introduction
As an immune privileged and easily accessible organ, the eye constitutes a favorable target for gene therapy. 1, 2 The identification of well-defined genetic targets for numerous ocular disorders such as Stargardt's disease and retinitis pigmentosa, render gene therapy a promising approach. [3] [4] [5] [6] Indeed, gene therapy for Leber Congenital Amaurosis has demonstrated promising and long-lasting results in clinical trials. [7] [8] Many recent studies have explored viruses such as adeno-associated virus in the field of ocular gene therapy. [9] [10] [11] [12] While relatively efficient, viral gene vectors are limited to some extent by technical difficulties in scale-up, high cost of production 13 and risk of mutagenesis. 14 Moreover, repeated administrations and prior exposures may cause neutralizing immune responses, in spite of the immune privileged environment of the eye. [15] [16] [17] The size cut-off for the expression cassette that can be packaged in viruses excludes the delivery of large transgenes that may be effective in monogenic ocular diseases. [18] [19] [20] Non-viral gene vectors constitute an alternative that can overcome most of the aforementioned limitations 21 in achieving ocular transgene delivery. [22] [23] However, important issues such as vehicle cytotoxicity, instability in physiological solutions as well as low level of cellular uptake, nuclear transfer and transgene expression limit the clinical applications of nano-carriers. 24 Various cationic polymer-based gene delivery systems, such as cationic dendrimers, have demonstrated effective transgene expression in vitro and in vivo 21 . The protonable amines of these gene vectors contribute to endosome escape and allow relatively high levels of transfection. 25 However, the same amine groups that enhance transfection lead to cytotoxicity, entrapment in physiological mesh-like barriers [26] [27] and tendency towards nanoparticle aggregation. For these reasons, a variety of new approaches are being explored to overcome the inherent limitations of cationic polymer based non-viral gene vectors. 21, 28 Several dendrimers, such as polyethylenimine (PEI) and polyamidoamine (PAMAM), have been used as non-viral gene delivery vectors with relatively promising results. [29] [30] [31] Amine-terminated PAMAM dendrimers demonstrate relatively high levels of transfection but are limited by cytotoxicity due to their amine-functionalized surface. 21, 32 Hydroxyl-terminated PAMAM dendrimers demonstrate improved safety profile and have proven to be effective drug and gene delivery vehicles. [33] [34] However, their near neutral surface charge and lack of protonatable amines impedes their use in nucleic acid compaction and transgene delivery. 35 Triamcinolone acetonide (TA) is an intermediate-acting, potent corticosteroid, administered intravitreally for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis and other ocular inflammatory conditions not responsive to systemic corticosteroids. Due to its neuroprotective and anti-angiogenic properties, TA has also previously been used as an adjuvant therapy for diabetic macular edema (DME), retinal vein occlusion, and some forms of age-related macular degeneration. [36] [37] [38] [39] In direct relevance to the present studies, TA has also been suggested to improve gene vector accumulation in the nucleus, as a nuclear localization signaling agent, dilating the nuclear pores up to 60 nm when bound to its receptor. 40 Ma et al.
have demonstrated that TA conjugation on PEI as well as cationic PAMAM dendrimers can significantly improve transgene expression of cationic polymer based gene vectors. [41] [42] We designed small compact gene vectors based on nearly neutral, hydroxyl-terminated PAMAM dendrimers functionalized with a minimal number of primary amine groups 43 to allow for efficient compaction while maintaining their favorable safety profile. We further utilized TA to offset the lack of protonatable amines and achieve high levels of safe transgene expression.
Additionally, we used a polyethylene glycol (PEG) surface coating to enhance colloidal stability of the aforementioned gene vectors in physiological solutions. We determined the physicochemical characteristics of the dendrimer-based gene vectors and examined the effect
High performance liquid Chromatography (HPLC)
The purity of the dendrimer conjugates was analyzed by HPLC (Waters Corporation, 
Fluorescence spectroscopy
Fluorescence spectra of the Cy5-conjugated dendrimer (BiD-TA-Cy5) were recorded in phosphate buffer (0.1M) using a Shimadzu RF-5301 spectrofluorometer with excitation at 645 nm and emission at 662 nm. To measure the fluorescence quantum yield of BiD-TA-Cy5 the absorbance at a wavelength of 645 nm and integrated fluorescence intensity following excitation at 645 nm of Cy5-conjugated dendrimer (BiD-TA-Cy5) and free Cy5 solutions at various concentrations were measured using the Synergy Mx Monochromator-Based Multi-Mode
Microplate reader (Biotek, Winooski, VT). The quantum yield was calculated using the previously described comparative method 47 .
Measurement of size and zeta potential of the conjugates
Dendrimer conjugates were dissolved at 1mg/mL in 10 mM NaCl at pH 7.0. The ζ-potential was measured by laser Doppler anemometry using a Nanosizer ZS90 (Malvern Instruments, Southborough, MA).
Buffering capacity of dendrimer conjugates
Dendrimer conjugates were dissolved at a concentration of 0.2 mg/mL in 5 mL of ultrapure DI water. Ultrapure water and PEI were used as a control. The initial pH was adjusted to 12.0 using 1.0 M NaOH and the solutions were titrated at 5 µL steps of 0.1 M HCl. The pH was measured using a microprocessor-based pH meter (Hanna instruments, Woonsocket, RI).
Dendrimer conjugate synthesis

Preparation of bifunctional dendrimer (BiD, 2)
Fmoc-functionalized dendrimer (BiD-Fmoc, 1) and amine functionalized bifunctional dendrimer (BiD, 2) were synthesized as previously described. 43 A brief summary is provided as part of supplement information. 
Synthesis of
Synthesis of bifunctional-Triamcinolone acetonide (BiD-TA, 4)
BiD-Fmoc-TA dendrimer (220 mg) was dissolved in anhydrous DMF (10 mL) and piperidine/DMF (2:8; 10 mL) was added to it under nitrogen. The reaction mixture was stirred for 30 min. and solvent was evaporated under vacuum at room temperature. The resultant crude product was subjected to dialysis in DMF (membrane MWCO = 1 kDa) for 24 h. The solvent was evaporated and the conjugate was re-dialyzed against water for 3-4 h and lyophilized to get BiD-TA, 4(145 mg) as off-white solid product. The BiD-TA has some free amine groups and TA molecules on the surface. 
Synthesis of Cy5-labeled bifunctional-triamcinolone acetonide dendrimer (BiD-TA-Cy5, 5)
The BiD-TA, 4 (15.5 mg, 0.0006 mmol) was dissolved in 2 ml of borate buffer (pH 9.0) at room temperature. The reaction mixture was cooled to 0°C and Cy5 mono NHS ester (0.72 mg, 0.00091 mmol) was added dissolved in 1 ml of DMSO. The reaction mixture was stirred overnight at room temperature to complete the reaction and lyophilized. The obtained crude product was dissolved in water and subjected to dialysis against pure DI water (membrane MWCO = 1 kDa) for 8h with successive change of water in every 2h. The resultant water layer
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2.3.6 Synthesis of amine dendrimer-mPEG2000 conjugate (G4-NH 2 -PEG, 6)
The G4-NH 2 dendrimer (100 mg, 0.007 mmol) was dissolved in borate buffer (10 mL) and EDC•HCl (134.5 mg) was added to it at 0°C. After 10 min mPEG2000 NHS ester was added and stirred the reaction mixture for 2 h. Finally the reaction mixture was dialyzed against water for 48 h (membrane cutoff: 8 kDa) and lyophilized to get PEG-functionalized dendrimer (G4- 
Gene vector formulation
Gene vector complexation
The pBAL was produced by Copernicus Therapeutics Inc. (Cleveland, OH) and pEGFP plasmid was purchased by Clontech Laboratories Inc. (Mountain View, CA). The plasmids were expanded and purified as previously described. 26 Plasmid was fluorescently labeled with Cy5 or The plasmid-polymer solutions were incubated for 30 min at room temperature to allow the formation of gene vectors. PEI and PEG-poly-L-lysine (PEG-PLL) gene vectors were formulated as previously described 26 and used as controls in the following experiments.
Gene vector characterization
The ζ-potential of the dendrimer complexes was measured in 10 mM NaCl at pH 7.0 by laser Doppler anemometry using a Nanosizer ZS90 (Malvern Instruments, Southborough, MA).
The hydrodynamic diameter and polydispersity of the gene vectors were measured in an ultrapure water solution by dynamic light scattering using a Nanosizer ZS90. In order to confirm their shape and size, the dendrimer-based gene vectors were imaged using transmission electron microscopy at 60,000x magnification (TEM, Hitachi H7600, Japan). Stability was assessed over time in ultrapure water at 4 o C as well as in PBS buffer in room temperature by dynamic light scattering using a Nanosizer ZS90. Gel retardation assay was preformed to assure efficient compaction of the plasmid DNA at different N/P ratios.
In vitro experiments in human retinal pigment epithelial cells
Cell culture
The human retinal pigment epithelial cell line (ARPE-19) was a kind gift from Dr. Gerard Lutty, Wilmer Eye Institute. Cells were cultured in Dulbecco's modified Eagle's medium, low glucose, pyruvate (DMEM, Life technologies, Grand Island, NY) supplemented with 1% penicillin/streptomycin (Invitrogen Corp., Carlsbad, CA) and 10% heat inactivated fetal bovine serum (FBS, Invitrogen Corp., Carlsbad, CA).
Transfection
To assess cell transfection, cells were seeded in 24-well plates at an initial concentration of 5.0 × 10 4 cells/well. After 24 h, cells were incubated with different dendrimer-based gene vectors carrying pBAL plasmid (2 μg of DNA/well) in media for 5 h at 37°C. Subsequently, culture media was replaced with fresh media. After additional 3 days of incubation at 37°C, media was removed and 0.5 mL of 1X Reporter Lysis Buffer was added. Cells were subjected to two freeze-and-thaw cycles to assure complete cell lysis, and supernatants were isolated by centrifugation. Luciferase activity in the supernatant was measured using a luciferase assay kit an FL4 band-pass filter with emission detection wavelength of 675/25 nm. Data were analyzed using the BD Accuri C6 software. The thresholds were set using untreated samples; cellular uptake of dendrimer-based gene vectors was compared to that of free plasmid uptake.
Cell uptake/Imaging
Similarly, for image-based analysis of gene vector cellular uptake; gene vectors formulated from BiD-TA-Cy5 and Cy3-labeled plasmid were administered to cells cultured in a 35 mm glass bottom culture dish (MatTek Corporation, Ashland, MA) stained with NucBlue®
Fixed Cell ReadyProbes® Reagent and imaged using confocal LSM 710 microscope over 12 h in a live cell imaging chamber. 
Gene vector toxicity
Results and Discussion
Dendrimer conjugates
Preparation and characterization of the bifunctional dendrimer (BiD, 2)
The preparation of the bifunctional dendrimer (BiD, 2) was prepared using Fmoc protection/deprotection chemistry as shown in Fig. 1A . 43 Our aim was to functionalize the dendrimer with approximately 20 amine groups out of the 64 hydroxyl end groups, so that it could be efficiently complexed with plasmid DNA. In brief, Fmoc-GABA-OH was reacted with the G4-OH dendrimer using PyBOP as a coupling reagent, to get Fmoc-functionalized intermediate 
Preparation of Triamcinolone acetonide-21-glutarate (TA-linker)
TA was functionalized with a carboxylic acid terminal group using glutaric acid as linker since an acid group is required to conjugate with the dendrimer according to a previously published procedure. 48 In brief, TA was reacted with glutaric anhydride dissolved in DMA/DMF mixture in presence of triethylamine (TEA) as base to get the TA-linker (Fig. 1B) . The TA-linker was characterized by 1 H NMR. TA has two reactive hydroxyl groups and the most reactive 21-position hydroxyl group has reacted with glutaric acid via ester bond. Apart from the protons signal from TA, an additional multiplet at 1.79 (CH 2 protons of linker), and two triplets at 2.32 and 2.47 (CH 2 protons of linker) confirmed the formation of the TA-linker. A characteristic peak at 12.12 ppm belonging to carboxylic acid confirmed that TA-linker has one acid group (Fig. S1 ).
Preparation of bifunctional-TA conjugate (BiD-TA, 4)
Synthesis of BiD-TA was performed using a three-step process with glutaric acid as a spacer, starting from G4-OH (Fig. 1A) . The Fmoc-functionalized dendrimer was reacted with TA-linker using PyBOP as the coupling reagent and DIEA as the base to get BiD-Fmoc-TA (3). In the final BiD-TA conjugate, 8 molecules of TA and 23 free amine groups were confirmed using the proton integration method (Fig. S3) . The lower number of TA and amine groups in the conjugate were due to hydrolysis of the ester bond with prolonged exposure to dialysis in DMF under basic conditions (presence of piperidine in the reaction mixture and traces of water in DMF). The BiD-TA conjugate was readily soluble in PBS buffer and saline solution, in contrast to TA which has poor water solubility. The retention time of BiD-TA in HPLC chromatogram at 20.1 min (monitored at 240 nm, PDA detector) confirms the conjugation of the TA to the dendrimer. At the same time, the retention time of BiD was 9.5 min (monitored at 210 nm).
Preparation of BiD-TA-Cy5 (5) conjugate
The BiD-TA (4) was labeled with Cy5, a near IR imaging agent, to study the internalization of the conjugate in RPE cells. We have previously reported the preparation of the dendrimer-Cy5 and characterized extensively using HPLC/GPC, NMR and fluorescence spectroscopy. 49 In brief, Cy5-mono-NHS ester was reacted with TA-functionalized bifunctional dendrimer (BiD-TA) in borate buffer to get Cy5-labeled dendrimers BiD-TA-Cy5 as shown in Fig. 1A . The final conjugate was purified by dialysis followed by GPC fractionation and characterized by reverse-phase HPLC and fluorescence spectroscopy. The HPLC trace showed a peak at 20.4 min. for BiD-TA-Cy5 (monitored at 645 nm excitation) different from BiD-TA and Cy5, confirming the formation of the conjugate. The fluorescence spectrum showed peaks at 648 nm (for excitation) and 663 nm (for emission) which follow a similar pattern to Cy5 also suggesting the conjugation of Cy5 to the dendrimer. Only one mole equivalent of Cy5 was used in each reaction and the percentage payload of the Cy5 to the dendrimer is ~4-5 wt%. The fluorescence quantum yield for the final conjugate was calculated to be 0.18, demonstrating a slight decrease compared to free Cy5 (~0.28).
Preparation of D-NH 2 -PEG (6) conjugate
The amine functionalized dendrimer (D-NH 2 ) was partially functionalized with 2K PEG to enhance the transfection efficiency of the dendrimer. In brief, NHS-ester of mPEG2000 was reacted with D-NH 2 dissolved in borate buffer to get the PEG functionalized dendrimer and was characterized by proton NMR. In the NMR chart, a peak at 3.25 ppm corresponds to OCH 3 peak of the PEG and multiplets between 3.36-3.66 ppm (methylene protons of PEG) along with dendrimer protons peaks in between 2.15-3.10 ppm confirm the formation of the conjugate. The loading of the PEG to the dendrimer was calculated by comparing the amidic protons of the dendrimer (8.02-8.24) to the backbone methylene protons of the PEG and found out that 7 molecules of the PEG were conjugated to the dendrimer.
Surface charge of dendrimer conjugates
BiD-TA and BiD ζ-potential were measured to be 13.9 mV and 12.9 mV, respectively.
Their surface charge was significantly lower than the ζ-potential of D-NH 2 
(22.2 mV). D-NH 2 -
PEG demonstrated significant shielding of the D-NH 2 positive surface charge resulting in a ζ-potential of 11.7 mV.
Dendrimer conjugates buffering capacity
As expected, BiD-TA and BiD demonstrated significantly lower buffering capacity in comparison to D-NH 2 and PEI, suggesting limited ability to buffer the lysosome environment and achieve endosome escape through the proton buffer effect, hence, underlying the importance of the incorporation of TA in order to improve the nuclear localization and transfection efficiency (Fig. S4 ).
Gene vector formulation and characterization
Using BiD as a base, we were able to formulate compact ~50 nm gene vectors with a nearly homogeneous size distribution (PDI: 0.16). Similarly, the conjugation of 8 TA molecules
did not appear to affect the complexation efficiency of these gene vectors, resulting in BiD-TA particles of similar size (~44 nm). We compared these gene vectors with conventional amineterminated PAMAM dendrimer-based gene vectors at the same N/P ratio. This formulation resulted in particles with similar physicochemical characteristics ( Fig. 2A &B and Table 1 ). We confirmed the spherical morphology and efficient plasmid compaction of these gene vectors using TEM (Fig. 2C) . The gene vectors were stable in an aqueous solution for at least 10 days (Fig. 2E) . However, once added into a high ionic strength solution (phosphate buffered saline, PBS), the particles rapidly aggregated and lost their colloidal stability. After one hour of incubation in PBS, BiD and BiD-TA reached a size of ~500 nm. D-NH 2 gene vectors aggregated at a slower rate and were ~300 nm in size at 1 hour (Fig. 2F) . To achieve successful transgene expression the gene vectors need to reach the target cells intact; the lack of stability and rapid aggregation imposes a serious obstacle to in vivo gene therapy.
In order to improve nanoparticle stability we formulated gene vectors using a blend of
BiD-TA and D-NH 2 -PEG. 26 This technique resulted in gene vectors of similar size (~50 nm) but a significantly lower ζ-potential of ~6 mV in comparison to that of non-coated nanoparticles (Fig. 2F ).
Gene vector cell uptake and transfection efficiency in retinal pigment epithelium
Transfection of BiD and BiD-TA was compared to D-NH 2 gene vectors as well as PEI and PEG-PLL gene vectors, which are widely used and are considered to be gold standards for non-viral gene delivery. 21, [50] [51] The use of BiD resulted in approximately 59-, 59000-and 29000-fold lower transfection efficiency in comparison to PEG-PLL, PEI and D-NH 2 respectively, in primary RPE cells. In contrast, incubation of BiD-TA gene vectors resulted in ~1700-fold higher transfection in comparison to PEG-PLL, and no statistically significant difference in transgene expression in comparison to PEI or D-NH 2 . BiD-TA transfection efficiency was 100000-fold higher than BiD (Fig. 3A) , underlying the important role of TA in improving transfection efficiency. These results were qualitatively confirmed using eGFP plasmid in combination with fluorescence microscopy (Fig. 3B-D) , which suggested that BiD-TA and D-NH 2 were comparable.
TA binds to the cytosolic glucocorticoid receptor (GR), which dilates the nuclear pores and translocate itself into the nucleus along with the gene carrier. [41] [42] Here, we take advantage of the high concentration of GR in human ARPE cells to achieve high-level transgene expression using hydroxyl terminated PAMAM dendrimer-based gene vectors. (Fig. 4A-E) . This is the first study to demonstrate not only improved transfection but also enhanced cellular uptake of TA conjugated gene vectors.
In order to confirm that the nanoparticles were able to enter the cells intact, we formulated BiD-TA gene vectors with 5% of amines contributed by Bi-D-Cy5 and Cy3-labeled plasmid. Fluorescence confocal microscopy and differential interference contrast (DIC) microscopy were combined to observe co-localized Cy3-plasmid and Cy5-dendrimer in the cell cytoplasm as well as the cell nucleus, indicating that dendrimer nanoparticles were able to be taken up and localize in the nucleus intact (Fig. 4F) , without disintegration during the endocytotic, and endosomal-lysosomal-nucleus transport.
Role of TA and PEG in cell uptake and transfection efficiency
In order to further understand the amount of TA required for effective cell uptake and transgene delivery, we repeated the cell uptake and transfection studies using dendrimer nanoparticles formulated from a blend of BiD-TA and BiD at a decreasing percent of amines contributed by BiD-TA ( Fig. 5A-H) . Varying the BiD-TA to BiD ratio did not result in significant change of the gene vector physicochemical characteristics (Table S1 ). More specifically, formulation of nanoparticles with 100%, 75%, 50%, 25%, 10% and 5% of amines contributed by (Fig. S5) . Therefore, partial PEGylation and the hydroxyl groups improves the toxicity profile of the delivery vectors.
Conclusion
In this study we attempted to address the inherent limitations of cationic-polymer based non-viral gene vectors. Using hydroxyl-functionalized PAMAM dendrimers, we achieved effective plasmid compaction, resulting in relatively small complexes using (a) a base-polymer with minimal amount of primary amine groups to minimize cytotoxicity, (b) TA as a nuclear localization signal to improve transfection and (c) a hydrophilic and near neutral PEG coating to improve stability in physiological solutions. We demonstrated efficient transgene delivery in hard to transfect human retinal pigment epithelial cells.
Cationic polymers with a high number of amine groups, such as PEI and amineterminated PAMAM dendrimers, have traditionally been used for efficient complexation. 21 We establish a new approach in which we minimally functionalized a hydroxyl PAMAM dendrimer, with or without the conjugation of TA, in order to achieve efficient compaction while retaining a reduced cytotoxicity profile in primary RPE cells. 26 to introduce a hydrophilic PEG coating which substantially reduces aggregation of the particles and increases the possibility of reaching the target cells intact, [26] [27] allowing for protection of the plasmid cargo 54 and more efficient cell uptake.
TA has previously demonstrated the ability to improve transgene expression and nuclear localization in human embryonic kidney and human hepatocellular carcinoma. [41] [42] In this study we used this attribute in order to offset the lack of buffering capacity, endosome escape and uptake. This phenomenon may be attributed to the nuclear localization of BiD-TA gene vectors leading to decreased exocytosis. 55 PEG coating has been suggested to reduce particle uptake by cells. [56] [57] However, in good agreement with previous studies on PEGylated cationic polymer based gene vectors, 52 we found that PEGylation did not affect cellular uptake. Their small particle size may contribute to Size and polydispersity (PDI) were measured by dynamic light scattering (DLS). ζ-potential was measured by Laser Doppler anemometry. Measurements were performed in 10mM NaCl at pH 7.0 and are presented as average of at least 3 measurements ± standard error (SEM).
